These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16872259)

  • 1. Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
    Koulenti D; Rello J
    Expert Opin Pharmacother; 2006 Aug; 7(12):1555-69. PubMed ID: 16872259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
    Siempos II; Vardakas KZ; Manta KG; Falagas ME
    Eur Respir J; 2007 Mar; 29(3):548-60. PubMed ID: 17329491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia.
    Montero A; Corbella X; Ariza J
    Crit Care Med; 2003 Oct; 31(10):2557-9. PubMed ID: 14530770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical approach to the patient with ventilator-associated pneumonia].
    Vidaur L; Ochoa M; Díaz E; Rello J
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():18-23. PubMed ID: 16854337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A; Sakalauskas R; Dudzevicius V
    Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De-escalation therapy in ventilator-associated pneumonia.
    Rello J; Vidaur L; Sandiumenge A; Rodríguez A; Gualis B; Boque C; Diaz E
    Crit Care Med; 2004 Nov; 32(11):2183-90. PubMed ID: 15640629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventilator associated pneumonia: risk factors, diagnosis, treatment and prevention].
    Pilvinis V; Stirbiene I
    Medicina (Kaunas); 2003; 39(11):1057-64. PubMed ID: 14646458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia?].
    Leone S; Fiore M; Felaco FM; Esposito S
    Infez Med; 2007 Mar; 15(1):16-23. PubMed ID: 17515671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline-based antibiotics and mortality in healthcare-associated pneumonia.
    Madaras-Kelly KJ; Remington RE; Sloan KL; Fan VS
    J Gen Intern Med; 2012 Jul; 27(7):845-52. PubMed ID: 22396110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Healthcare-associated pneumonia - is this new entity important for diagnosis and treatment of pneumonia? pro].
    Schaaf B
    Dtsch Med Wochenschr; 2010 Mar; 135(10):466. PubMed ID: 20198544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ventilator-associated pneumonia and multiresistant bacteria].
    Heininger A; Unertl K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.
    Vazquez Guillamet C; Kollef MH
    Clin Infect Dis; 2018 Oct; 67(9):1455-1462. PubMed ID: 29741597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which antibiotic for hospital acquired pneumonia caused by MRSA?
    Muscedere J
    BMJ; 2014 Feb; 348():g1469. PubMed ID: 24525051
    [No Abstract]   [Full Text] [Related]  

  • 20. Consensus document on nosocomial pneumonia.
    Froes F; Paiva JA; Amaro P; Baptista JP; Brum G; Bento H; Duarte P; Dias CS; Glória C; Estrada H; Telo L; Silva E; Pereira JG; do Carmo G;
    Rev Port Pneumol; 2007; 13(3):419-86. PubMed ID: 17695078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.